Blood stem cell transplants come of age.
In this report we review meeting highlights. Clearly there has been substantial progress in the laboratory and clinic with regard to blood stem cells. Having proven that these transplants work, it is now time to investigate biologic features in greater detail. Also needed are randomized trials evaluating several of the issues we raise such as whether the better results of blood cell autotransplants are due to more effective treatment or subject selection and whether in vitro removal of tumor cells is necessary or effective.
Department of Medicine, UCLA School of Medicine 90024-1678.
R P
RP
Gale
P
P
Henon
C
C
Juttner
D001773:Blood Cells / Q000637:transplantation; D001803:Blood Transfusion / Q000639:trends; D016026:Bone Marrow Transplantation / Q000639:trends*; D005312:Fetal Blood / Q000166:cytology; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009369:Neoplasms / Q000601:surgery / Q000628:therapy; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D016298:Hematopoietic Cell Growth Factors